CD19 and type 1 diabetes mellitus: However, there was no significant difference in mOX40L on CD19+ B cells between T1D patients and HC (10.76 ± 0.93% vs. 12.02 ± 1.62%, p = 0.782) (Figures 1(c) and 1(d)).